Ewch i’r prif gynnwys

Takeda

Mae'r cynnwys hwn ar gael yn Saesneg yn unig.

Takeda
Professor Emiliangelo Ratti, head of Neuroscience Therapeutic Area for the Takeda Corporation worldwide.

Cardiff University has formed a partnership with Takeda Pharmaceutical Company Limited (Takeda) for a drug discovery collaboration to identify new approaches for treating schizophrenia and other psychiatric disorders.

The collaboration will combine the University's large scale genomic data and world-class expertise in psychiatric genetics, genomics, clinical and basic neuroscience with Takeda’s extensive drug discovery and clinical development capabilities.

The collaboration will allow Takeda access to world-leading biological psychiatry research and the related infrastructure across the University, including the

Enquiries

For more information regarding the Takeda partnership, please contact:

Yr Athro Lawrence Wilkinson

Yr Athro Lawrence Wilkinson

Scientific Director, Neuroscience and Mental Health Research Institute.

Email
wilkinsonl@caerdydd.ac.uk
Telephone
+44(0) 29 2068 8461